BrainQ raises $5.3M to treat neurological concerns with the succor of AI


BrainQ, an Israel-based totally startup that objectives to succor stroke victims and those with spinal cord accidents treat their accidents with the succor of a personalized electromagnetic remedy protocol, lately launched that it has raised a $5.three million funding spherical on top of the $three.5 million the corporate beforehand raised. The corporate’s investors encompass Qure Ventures, crowdfunding platform, Norma Investments, IT-Farm and a alternative of angel investors, along with Valtech Cardio founder and CEO Amir Putrid.

After we final talked to BrainQ earlier this 365 days, the crew used to be engaged on two human clinical trials for stroke sufferers in Israel. At that point, the corporate had closed its first funding spherical and had additionally lately began to work with Google’s Launchpad Accelerator, too.

The basic conception in the support of BrainQ is to make employ of the patient’s brainwaves to generate a tailored remedy protocol. No AI company would be total with out records — it’s what drives these algorithms, despite all the pieces — and the corporate says it owns one the finest Mind Computer Interface-based totally EEG databases for motor responsibilities. It’s that database that allows it to interpret the patient’s brain waves and generate its remedy protocol.

BrainQ EEG reader tool

“We’re on the verge of a recent generation where AI- based totally precision medication shall be aged to treat neurodisorders, which attain no longer possess a passable solution as a lot as now,” acknowledged BrainQ CEO Yotam Drechsler in lately’s announcement. “At BrainQ, we are extremely satisfied by the alternative to relate this vision to life on the earth of neuro-recovery. In a quick whereas, we now possess already carried out significant outcomes and are taking a seek forward to the alternative to push our technology and enlarge our operations, further positioning BrainQ as a frontrunner on the earth of BCI-based totally precision medication.”

As is traditional for Israeli startups, the crew’s background is terribly impressive and comprises aged people of the nation’s elite intelligence models and lecturers with a background in AI and neuroscience.

Learn More


Comments are closed.